Publication November 7, 2026

Corrigendum Published for Lixisenatide Parkinson's Mouse Study

A corrigendum related to lixisenatide was published on November 7, 2026, in the journal Neuroscience. The corrigendum pertains to the article titled "Neuroprotective effects of lixisenatide and liraglutide in the MPTP mouse model of Parkinson's disease," originally published in Neuroscience 303 (2015), pages 42 to 50.

The event recorded is the publication of this corrigendum, not new research findings. No details about the specific corrections made to the original article are included in the available data. The original article examined lixisenatide and liraglutide in a mouse model of Parkinson's disease using the MPTP model, as indicated by the title.

Lixisenatide remains an approved compound. This item reflects only the existence and date of the corrigendum publication in Neuroscience, as recorded in the source material. No efficacy, safety, or outcome data from the original study or the corrigendum itself are described here.

Readers interested in additional background can consult the compound overview for further context on lixisenatide.

See the full lixisenatide overview

Source: https://pubmed.ncbi.nlm.nih.gov/42998608/